Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

High-Sensitivity Hematopoietic Chimerism By qPCR For Relapse Prediction and Specific Identification Of HLA Loss Leukemic Variants

Luca Vago, MD, PhD, Benedetta Mazzi, BSc, Lorenza Chiesa, BSc, Raffaella Greco, MD, Cinzia Pultrone, MSc, Eleonora Toffoletti, MD, Cristina Toffalori, PhD, Pietro Crivello, PhD, Veronica Tettamanzi, MSc, Lara Crucitti, MD, Maria Teresa Lupo Stanghellini, MD, Andrea Assanelli, MD, Consuelo Corti, MD, Massimo Bernardi, MD, Jacopo Peccatori, MD, Chiara Bonini, MD, Douglas A. Bost, PhD, Fabio Ciceri, MD, Katharina Fleischhauer, MD

Blood (2013) 122 (21): 3313.

https://doi.org/10.1182/blood.V122.21.3313.3313

Published: 2013

Journal Articles

Non-Linear Clonal Evolution Of Leukemia Driven By Selective Immune Pressure and Revealed By HLA Typing and High-Depth Exome Sequencing

Luca Vago, MD, PhD, Davide Cittaro, PhD, Dejan Lazarevic, MD, Cristina Toffalori, PhD, Giacomo Oliveira, MSc, Lorenza Chiesa, BSc, Benedetta Mazzi, BSc, Maurilio Ponzoni, MD, Matteo Carrabba, MD, Massimo Bernardi, MD, Jacopo Peccatori, MD, Claudio Bordignon, MD, Chiara Bonini, MD, Katharina Fleischhauer, MD, Fabio Ciceri, MD, Elia Stupka, PhD

Blood (2013) 122 (21): 1369.

https://doi.org/10.1182/blood.V122.21.1369.1369

Published: 2013

Journal Articles

Incidence, Risk Factors and Clinical Outcome Of Leukemia Relapses Due To Loss Of The Mismatched HLA Haplotype After Partially-Incompatible Hematopoietic Stem Cell Transplantation

Lara Crucitti, MD, Roberto Crocchiolo, MD, PhD, Cristina Toffalori, PhD, Maria Teresa Lupo Stanghellini, MD, Andrea Assanelli, MD, Matteo Carrabba, MD, Benedetta Mazzi, BSc, Elisabetta Zino, BSc, Sarah Marktel, MD, Magda Marcatti, MD, Consuelo Corti, MD, Massimo Bernardi, MD, Jacopo Peccatori, MD, Claudio Bordignon, MD, Chiara Bonini, MD, Katharina Fleischhauer, MD, Fabio Ciceri, MD, Luca Vago, MD, PhD

Blood (2013) 122 (21): 918.

https://doi.org/10.1182/blood.V122.21.918.918

Published: 2013

Journal Articles

Improved Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Metastatic Renal Cancer Associated with Homozygosity for the HLA-G 14 Base-Pair Deletion Polymorphism: An EBMT STWP Study

Benedetta Mazzi, BSc, Roberto Crocchiolo, MD, Didier Blaise, MD, Lisbeth Barkholt, MD, Jacques-Olivier Bay, MD, PhD, Rocco Pastano, MD, Margherita Torchio, PhD, Stefania Trinca, DM, Jacopo Peccatori, MD, Fabio Ciceri, MD, Katharina Fleischhauer, MD, Marco Bregni, MD

Blood (2012) 120 (21): 4667.

https://doi.org/10.1182/blood.V120.21.4667.4667

Published: 2012

Journal Articles

Loss of Mismatched HLA At Leukemia Relapse After Hematopoietic Stem Cell Transplantation Is Significantly Associated with Clinical and Immunogenetic Hallmarks of Donor-Versus-Host Alloreactivity

Lara Crucitti, MS, Luca Vago, MD PhD, Roberto Crocchiolo, MD PhD, Cristina Toffalori, MSc, Maria Teresa Lupo Stanghellini, MD, Andrea Assanelli, MD, Matteo Carrabba, MD, Benedetta Mazzi, BSc, Elisabetta Zino, BSc, Sarah Marktel, MD, Magda Marcatti, MD, Consuelo Corti, MD, Massimo Bernardi, MD, Jacopo Peccatori, MD, Claudio Bordignon, MD, Chiara Bonini, MD, Katharina Fleischhauer, MD, Fabio Ciceri, MD

Blood (2012) 120 (21): 1957.

https://doi.org/10.1182/blood.V120.21.1957.1957

Published: 2012

NARROW

High-Sensitivity Hematopoietic Chimerism By qPCR For Relapse Prediction and Specific Identification Of HLA Loss Leukemic Variants

Non-Linear Clonal Evolution Of Leukemia Driven By Selective Immune Pressure and Revealed By HLA Typing and High-Depth Exome Sequencing

Incidence, Risk Factors and Clinical Outcome Of Leukemia Relapses Due To Loss Of The Mismatched HLA Haplotype After Partially-Incompatible Hematopoietic Stem Cell Transplantation

Improved Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Metastatic Renal Cancer Associated with Homozygosity for the HLA-G 14 Base-Pair Deletion Polymorphism: An EBMT STWP Study

Loss of Mismatched HLA At Leukemia Relapse After Hematopoietic Stem Cell Transplantation Is Significantly Associated with Clinical and Immunogenetic Hallmarks of Donor-Versus-Host Alloreactivity

Email alerts

ASH Publications

American Society of Hematology

High-Sensitivity Hematopoietic Chimerism By qPCR For Relapse Prediction and Specific Identification Of HLA Loss Leukemic Variants

Non-Linear Clonal Evolution Of Leukemia Driven By Selective Immune Pressure and Revealed By HLA Typing and High-Depth Exome Sequencing

Incidence, Risk Factors and Clinical Outcome Of Leukemia Relapses Due To Loss Of The Mismatched HLA Haplotype After Partially-Incompatible Hematopoietic Stem Cell Transplantation

Improved Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Metastatic Renal Cancer Associated with Homozygosity for the HLA-G 14 Base-Pair Deletion Polymorphism: An EBMT STWP Study

Loss of Mismatched HLA At Leukemia Relapse After Hematopoietic Stem Cell Transplantation Is Significantly Associated with Clinical and Immunogenetic Hallmarks of Donor-Versus-Host Alloreactivity

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only